
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol | India News
[ad_1] Dr Krishna Ella executive chairman Bharat Biotech HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes.The Hyderabad-based vaccine maker said Hillchol showed an over four-fold rise in vibriocidal antibodies—68.3% for Ogawa and 69.5% for Inaba serotypes….